# Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

> **NCT00514059** · PHASE4 · COMPLETED · sponsor: **Norwegian Institute of Public Health** · enrollment: 83 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis
- Polio

## Interventions

- **DRUG:** Boostrix polio

## Key facts

- **NCT ID:** NCT00514059
- **Lead sponsor:** Norwegian Institute of Public Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2007-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514059, "Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00514059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*